Sure, no worries.
Gen 1 (in hospital unit) will not be used to make treatment decisions as a first port of call - EXCEPT - in the absence of CT or MRI. Rural hospitals are less likely to have readily available access to CT and MRI and therefore EMV Gen 1 will be ideal to fill that need.
Of course in the future Gen 2 will intercede this decision making process in the field but until then CT and MRI will be used first and Gen 1 more for in ward monitoring and then follow up scans.
There are more rural opportunities in the US.
I hope this makes sense.
Random AGM notes & quotes, page-6
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.02 |
Change
0.033(1.64%) |
Mkt cap ! $172.5M | |||
| Open | High | Low | Value | Volume |
| $1.98 | $2.02 | $1.94 | $41.93K | 21.40K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1272 | $1.96 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.03 | 4500 | 1 |
View Market Depth
| Last trade - 16.10pm 30/07/2024 (20 minute delay) ? |
| EMV (ASX) Chart |